BEGIN:VCALENDAR VERSION:2.0 METHOD:PUBLISH PRODID:-//Telerik Inc.//Sitefinity CMS 14.4//EN BEGIN:VTIMEZONE TZID:Mountain Standard Time BEGIN:STANDARD DTSTART:20231102T020000 RRULE:FREQ=YEARLY;BYDAY=1SU;BYHOUR=2;BYMINUTE=0;BYMONTH=11 TZNAME:Mountain Standard Time TZOFFSETFROM:-0600 TZOFFSETTO:-0700 END:STANDARD BEGIN:DAYLIGHT DTSTART:20230301T020000 RRULE:FREQ=YEARLY;BYDAY=2SU;BYHOUR=2;BYMINUTE=0;BYMONTH=3 TZNAME:Mountain Daylight Time TZOFFSETFROM:-0700 TZOFFSETTO:-0600 END:DAYLIGHT END:VTIMEZONE BEGIN:VEVENT DESCRIPTION:The \;CCTSI\, in collaboration with \;Venture Partners at CU Boulder\, CSU Ventures\, Colorado State University and the CU Anschu tz NIH funded Research Evaluation and Commercialization Hubs (REACH) progr am \;presents \;Ask the Expert: adVentures in Innovation.\nOn Augu st 9\, 2021 at noon \;Richard C. Duke\, Ph.D. \;will present \ ;Tying it all Together: Inventor\, Biomedical Researcher\, Executive and S erial Entrepreneur. \;\nDr. Duke has more than 20 years of experience in building\, financing and managing start-up biotechnology companies base d on inventions made in Colorado&rsquo\;s non-profit research institutions . He is currently the Principal Investigator and Co-Director of the Univer sity of Colorado Anschutz Medical Campus Research Evaluation and Commercia lization Hub (REACH) and was the Founder and Chief Scientific Officer of t he Colorado Institute for Drug\, Device and Diagnostic Development (CID4). Dr. Duke is a Co-scientific Founder and former CEO of GlobeImmune (NASD:G BIM) and was involved in the formation and/or management of Newellink\, Ap opLogic Pharmaceuticals\, Sierra Neuropharmaceuticals\, MenoGeniX\, Aurora Oncology and AMP Discovery. \;\n \;\nIn addition to his entrepren eurial activities\, Dr. Duke has more than 35 years of experience in biome dical research and is a tenured faculty member in the Department of Medici ne (Medical Oncology) at the University of Colorado School of Medicine. He has provided independent third party research analysis in the life scienc es sector to Janus Capital and to venture capital firms.\n \;\nHe is a graduate of McGill University (B.Sc. and M.Sc.) and the University of Col orado (Ph.D.). Dr. Duke strongly believes in the merits and opportunities that arise from building new companies based on university technologies an d enjoys working with academic entrepreneurs.\nThis lunchtime series is de signed for researchers and academics who are interested in entrepreneurshi p\, pharmaceutical\, device and technology development and innovation.&nbs p\;\n\nEach month\, skillful interviewers will engage in an enlightening c onversation with an expert\, followed by a Q&\;A session.\n\n The se ries will take place on Zoom. \;\n\n\n The next session will take p lace Monday\, August 9\, 2021 at 12 noon (MT). \;\n Dr. Richard Duk e will be interviewed by Dr. Cathy Bodine\, Director\, Innovation Ecosyste ms\, CCTSI. \;\n\nLearn more and register for the session.\nFor questi ons\, contact \;Tara.Calhoun@cuanschutz.edu. DTEND:20210809T190000Z DTSTAMP:20240328T080128Z DTSTART:20210809T180000Z LOCATION: SEQUENCE:0 SUMMARY:Ask the Expert: adVentures in Innovation UID:RFCALITEM638471880885180217 X-ALT-DESC;FMTTYPE=text/html:
The \;CCTSI\, in colla boration with \;Venture Partners at CU Boulder\, CSU Ventures\ , Colorado State University and the CU Anschutz NIH funded Research Evalua tion and Commercialization Hubs (REACH) program \;presents&nb sp\;Ask the Expert: adVentures in Innovation.
\nOn August 9\, 2 021 at noon \;Richard C. Duke\, Ph.D. \;will pres ent \;Tying it all Together: Inventor\, Biomedical Researcher\, Ex ecutive and Serial Entrepreneur. \;
\nDr. Duke has more tha n 20 years of experience in building\, financing and managing start-up bio technology companies based on inventions made in Colorado&rsquo\;s non-pro fit research institutions. He is currently the Principal Investigator and Co-Director of the University of Colorado Anschutz Medical Campus Research Evaluation and Commercialization Hub (REACH) and was the Founder and Chie f Scientific Officer of the Colorado Institute for Drug\, Device and Diagn ostic Development (CID4). Dr. Duke is a Co-scientific Founder and former C EO of GlobeImmune (NASD:GBIM) and was involved in the formation and/or man agement of Newellink\, ApopLogic Pharmaceuticals\, Sierra Neuropharmaceuti cals\, MenoGeniX\, Aurora Oncology and AMP Discovery. \;
\n  \;
\nIn addition to his entrepreneurial activities\, Dr. Duke has mo re than 35 years of experience in biomedical research and is a tenured fac ulty member in the Department of Medicine (Medical Oncology) at the Univer sity of Colorado School of Medicine. He has provided independent third par ty research analysis in the life sciences sector to Janus Capital and to v enture capital firms.
\n \;
\nHe is a graduate of McGill U niversity (B.Sc. and M.Sc.) and the University of Colorado (Ph.D.). Dr. Du ke strongly believes in the merits and opportunities that arise from build ing new companies based on university technologies and enjoys working with academic entrepreneurs.
\nThis lunchtime series is designed for res earchers and academics who are interested in entrepreneurship\, pharmaceut ical\, device and technology development and innovation. \;
\np>\n
Each month\, skillful interviewers will engage in an enlightening c onversation with an expert\, followed by a Q&\;A session.
\nLearn more and register for the session a>.
\n